Results 181 to 190 of about 50,237 (216)

The past, present, and future treatment of BRAF^V600-mutant metastatic colorectal cancer: A comprehensive review. [PDF]

Cancer
Dirven I, Ang C, Bertels C, Kortbeek K, de Haar-Holleman A, Vollebergh M, Poulikakos P, Neyns B.   +7 more
europepmc   +1 more source

Immunotherapeutic Approaches to Head and Neck Squamous Cell Carcinoma: Current Clinical Practice and Future Directions. [PDF]

Head Neck
Bradford CR, M P S, Rao KN, Guntinas-Lichius O, Saba N, Ferlito A.   +5 more
europepmc   +1 more source

Radiotherapy with or without concurrent cetuximab in HPV-positive oropharyngeal squamous cell carcinoma - A pooled analysis from two ARTSCAN trials. [PDF]

Clin Transl Radiat Oncol
Adrian G, Nilsson P, Friesland S, Cange HH, Söderkvist K, Reizenstein J, Zackrisson B, Gebre-Medhin M.   +7 more
europepmc   +1 more source

Digital Twins for Targeted Therapy in Head and Neck Cancer: From Molecular Stratification to Resistance-Aware Combination Strategies. [PDF]

Curr Oncol
Gonçalves F, Gonçalves M, Barata P, Vale N.   +3 more
europepmc   +1 more source

Quantifying molecular specificity in excipient-driven antibody solubilization. [PDF]

MAbs
Han Z, Erkamp NA, Scrutton R, Licari G, Predeina O, Evers A, Sormanni P, Knowles TPJ.   +7 more
europepmc   +1 more source

Extending the utility of anti-EGFR therapy in metastatic colorectal cancer. [PDF]

J Gastrointest Oncol
Cann C, Vijayvergia N.
europepmc   +1 more source

The Role of Monoclonal Antibody Targeted Therapy (Panitumumab) in the Treatment of Metastatic Colorectal Cancer-A Narrative Review of Current Evidence and Emerging Therapeutic Strategies. [PDF]

Int J Mol Sci
Kwiatkowska L, Szczuko M.
europepmc   +1 more source

Paclitaxel, carboplatin, and cetuximab induction chemotherapy for locally advanced head and neck squamous cell carcinoma: A retrospective evaluation of treatment outcomes and safety. [PDF]

Curr Ther Res Clin Exp
Iijima H, Sakai A, Yamauchi M, Obata K, Watanabe T, Fukuzawa T, Kuroki T, Teramura T, Yamazaki A, Inagi T, Sato Y, Yamamoto A, Ashida H, Ota Y, Kobayashi N, Tanimizu H, Maki D, Ebisumoto K, Wasano K, Okami K.   +19 more
europepmc   +1 more source

Efficacy of dual KRAS^G12D-EGFR blockade versus triple combinations in patient-derived models of KRAS^G12D-mutant colorectal cancer. [PDF]

Cell Death Dis
Leto SM, Sassi F, Zanella ER, Vurchio V, Cottino F, Ferri M, Damico A, Grassi E, Bertotti A, Trusolino L.   +9 more
europepmc   +1 more source

Contrasting temporal dynamics of fluorescence and photoacoustic signals from Cetuximab-IRDye800 conjugate in EGFR-overexpressing tumors. [PDF]

Sci Adv
Saad MA, Allen D, Sweeney A, Xavierselvan M, Mallidi S, Hasan T.   +5 more
europepmc   +1 more source